Givaudan reports CHF 5,891 million in nine-month sales: stock pre-market at EUR 4,065.50
Published on 10/14/2026 at 08:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSSales Momentum And Dates
- Givaudan reported CHF 5,891 million in nine-month sales on October 13, 2026.
- Givaudan stock was at EUR 4,065.50 pre-market at 8:07 a.m. CEST on October 14, 2026, at Lang & Schwarz.
- Givaudan scheduled its full-year results for January 27, 2027.
Givaudan reported CHF 5,891 million in sales for the first nine months of 2026 on October 13, while the stock was at EUR 4,065.50 pre-market at Lang & Schwarz at 8:07 a.m. CEST on October 14.
Pre-market trading
Givaudan stock was at EUR 4,065.50 at Lang & Schwarz at 8:07 a.m. CEST on October 14, 2026. Bid and ask prices were EUR 4,059.00 and EUR 4,072.00, respectively. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Givaudan stock.
What matters today
Givaudan's next scheduled company date is its full-year results publication on January 27, 2027. A round-number reference level is EUR 4,100, which is 0.85 percent above the pre-market price. Givaudan's 2030 strategy targets average like-for-like sales growth of 4 percent to 6 percent over the five-year period.
Nine-month sales performance
According to the company's October 13 release, sales increased 5.2 percent on a like-for-like basis and 2.6 percent in Swiss francs compared with the first nine months of 2025. Fragrance & Beauty sales reached CHF 3,150 million, up 8.8 percent on a like-for-like basis, while Taste & Wellbeing sales were CHF 2,741 million, up 1.5 percent on the same basis. Givaudan said its 2030 strategy includes a target of more than 12 percent average adjusted free cash flow over the period. The company also said full-year results are scheduled for January 27, 2027. These figures and dates are reported in the Givaudan release.
Market context: Market report SMI.
